NGM Biopharmaceuticals, Inc. Gross Profit 2019-2023 | NGM
NGM Biopharmaceuticals, Inc. gross profit from 2019 to 2023. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
| NGM Biopharmaceuticals, Inc. Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2023 | $4 |
| 2022 | $55 |
| 2021 | $78 |
| 2020 | $87 |
| 2019 | $104 |
| 2018 | $109 |
| 2017 | $77 |
| NGM Biopharmaceuticals, Inc. Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2023-12-31 | $0 |
| 2023-09-30 | $1 |
| 2023-06-30 | $1 |
| 2023-03-31 | $2 |
| 2022-12-31 | $18 |
| 2022-09-30 | $8 |
| 2022-06-30 | $8 |
| 2022-03-31 | $21 |
| 2021-12-31 | $21 |
| 2021-09-30 | $19 |
| 2021-06-30 | $17 |
| 2021-03-31 | $22 |
| 2020-12-31 | $20 |
| 2020-09-30 | $23 |
| 2020-06-30 | $20 |
| 2020-03-31 | $24 |
| 2019-12-31 | $31 |
| 2019-09-30 | $22 |
| 2019-06-30 | $25 |
| 2019-03-31 | $26 |
| 2018-12-31 | $47 |
| 2018-09-30 | $21 |
| 2018-06-30 | $22 |
| 2018-03-31 | $19 |
